Clarifying transfusion‐associated graft‐versus‐host disease risk in modern Hodgkin lymphoma survivorship

Key Points

• To clarify the risk of transfusion-associated graft-versus-host disease in survivors of Hodgkin lymphoma.
• Review of existing literature on transfusion-associated risks
• Evaluation of current practices in survivorship care
• Identified key factors influencing graft-versus-host disease risk in transfusions
• Highlighted the importance of tailored transfusion protocols for Hodgkin lymphoma survivors